Live Analyst Rating Changes 1505 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Benjamin Rossi
JPM
Benjamin Rossi
J.P. Morgan
Wall Street Analyst
★★★★☆
#646
on 13Foresight · ranked by our own returns
60%
Success Rate
+6.8%
Average Return
6 of 10 calls profitable · +0.3% vs benchmark
📈 Across the calls we could measure, roughly 60% of Benjamin Rossi's ratings turned a profit when each position was held for 1 year — averaging +6.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

17 Buy 17 Hold 2 Sell
Benjamin's Stock Coverage 12 ratings · 2026-06-18
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
GMRS
GMR Solutions, Inc. Class A
 Jun 08, 2026 BUY Strong Buy
+58.8% avg upside
8 analysts
$15.00
13.72% Upside
 ·
LMRI
Lumexa Imaging Holdings, Inc.
 May 25, 2026 BUY Strong Buy
+108.4% avg upside
8 analysts
$18.00
98.29% Upside
 -4.8%
HCA
HCA Healthcare
 May 22, 2026 HOLD Buy
+11.5% avg upside
35 analysts
$490.00
29.53% Upside
 -1.8%
THC
Tenet Healthcare
 May 22, 2026 BUY Strong Buy
+22.3% avg upside
26 analysts
$260.00
48.32% Upside
 +2.7%
UHS
Universal Health
 May 22, 2026 HOLD Buy
+50.2% avg upside
22 analysts
$205.00
44.69% Upside
 -10.4%
CON
Concentra Group Holdings Parent, Inc.
 May 22, 2026 BUY Strong Buy
+10.4% avg upside
9 analysts
$34.00
17.94% Upside
 ·
USPH
US Physical Therapy
 May 18, 2026 BUY Strong Buy
+45.3% avg upside
12 analysts
$90.00
42.65% Upside
 -1.7%
PACS
PACS Group Inc
 Apr 01, 2026 BUY Strong Buy
+22.7% avg upside
9 analysts
$44.00
21.74% Upside
 +9.8%
SGRY
Surgery Partners
 Mar 27, 2026 HOLD Strong Buy
+72.0% avg upside
18 analysts
$14.00
2.71% Downside
 +31.8%
AVAH
Aveanna Healthcare Holdings
 Mar 27, 2026 HOLD Buy
+19.6% avg upside
17 analysts
$8.00
3.41% Upside
 +19.6%
INNV
InnovAge Holding
 Feb 23, 2026 SELL Sell
-20.3% avg upside
12 analysts
$7.00
23.81% Downside
 +20.2%
ARDT
Ardent Health Partners, Inc.
 Nov 24, 2025 HOLD Buy
+50.2% avg upside
16 analysts
$12.00
33.45% Upside
 +2.2%
🔒 7 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Benjamin Rossi — Frequently Asked Questions
How accurate are Benjamin Rossi's stock ratings?
Based on the calls 13Foresight could measure, about 60% of Benjamin's ratings were profitable over a one-year hold, with an average return of +6.8% per rating, or +0.3% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Benjamin ranked on 13Foresight?
Benjamin Rossi is currently ranked #646 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Benjamin cover?
Benjamin most recently has ratings on GMRS, LMRI, HCA, THC, UHS, CON, USPH, PACS, SGRY, AVAH, INNV, ARDT. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.